Abstract
Children affected by acute virus respiratory infection running its course with characteristic symptoms of rhinitis, pharyngitis, tonsillitis, and acute bronchitis were administered combination therapy with a new pharmaceutical valcophen in a tablet form. In a clinical trial of the above drug, gratifying therapeutic results were found to be obtainable with a 2-to-3 day course of treatment at minimum dosage.
Publication types
-
Clinical Trial
-
English Abstract
MeSH terms
-
Acute Disease
-
Adolescent
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
-
Aspirin / therapeutic use*
-
Caffeine / therapeutic use*
-
Child
-
Child, Preschool
-
Drug Combinations
-
Drug Therapy, Combination
-
Female
-
Humans
-
Male
-
Neurotic Disorders / complications
-
Phenobarbital / therapeutic use*
-
Respiratory Tract Infections / drug therapy
-
Tablets
-
Virus Diseases / drug therapy
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Drug Combinations
-
Tablets
-
valcophen
-
Caffeine
-
Aspirin
-
Phenobarbital